Martin van den Bent

All papers authored by Martin van den Bent

This paper was not found in any repository, but could be made available legally by the author.

2022 Antonio Omuro, Alba A. Brandes, Antoine F. Carpentier, Ahmed Idbaih

, David A. Reardon, Timothy Cloughesy, Ashley Sumrall, Joachim Baehring, Martin van den Bent

, Oliver Bähr, Giuseppe Lombardi

, Paul Mulholland

, Ghazaleh Tabatabai

, Ulrik Lassen, Juan Manuel Sepulveda and 14 other authors

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

Upload

Kaspar Draaisma, C. Mircea S. Tesileanu, C. Mircea S. Tesileanu

, Iris de Heer, Martin Klein

, Marion Smits, Jaap C. Reijneveld, Paul M. Clement

, Filip Y. F. de Vos

, Antje Wick, Paul J. Mulholland

, Martin J. B. Taphoorn, Michael Weller

, Olivier L. Chinot

, Johan M. Kros

and 8 other authors

Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial

Upload

C. Mircea S. Tesileanu

, Thierry Gorlia, Vassilis Golfinopoulos, Pim J. French, Martin J. van den Bent

MGMT promoter methylation determined by the MGMT-STP27 algorithm is not predictive for outcome to temozolomide in IDH-mutant anaplastic astrocytomas

Upload

This paper is made freely available by the publisher.

Renske Gahrmann

, Marion Smits

, René Michel Vernhout, Walter Taal

, Giorgios Kapsas, Jan Cees de Groot, Monique Hanse, Maaike Vos, Laurens Victor Beerepoot, Jan Buter, Zwenneke Hendrieke Flach, Bronno van der Holt, Martin van den Bent

The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab

Download from doi.org

2021 C. Mircea S. Tesileanu, C. Mircea S. Tesileanu

, Martin J. van den Bent

, Marc Sanson, Wolfgang Wick

, Alba A. Brandes, Paul M. Clement, Sara C. Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean F. Baurain, Warren P. Mason, Helen Wheeler, Olivier L. Chinot, Sanjeev Gill and 24 other authors

Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2020 Philipp Kickingereder

, Gianluca Brugnara

, Mikkel Bo Hansen

, Martha Nowosielski

, Irada Pflüger, Marianne Schell, Fabian Isensee

, Martha Foltyn

, Ulf Neuberger

, Tobias Kessler

, Felix Sahm

, Antje Wick

, Sabine Heiland

, Michael Weller

, Michael Platten

and 7 other authors

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial

Upload

Jerrold L. Boxerman

, Chad C. Quarles, Leland S. Hu, Bradley J. Erickson, Elizabeth R. Gerstner, Marion Smits, Timothy J. Kaufmann, Daniel P. Barboriak

, Raymond H. Huang, Wolfgang Wick

, Michael Weller

, Evanthia Galanis, Jayashree Kalpathy-Cramer, Lalitha Shankar, Paula Jacobs and 16 other authors

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Upload

2019 Martin van den Bent

, Analia Azaro, Filip De Vos

, Juan Sepulveda, W. K. Alfred Yung, Patrick Y. Wen, Andrew B. Lassman, Markus Joerger, Ghazaleh Tabatabai

, Jordi Rodon, Ralph Tiedt, Sylvia Zhao, Tiina Kirsilae, Yi Cheng, Sergio Vicente and 3 other authors

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma

Upload

Martin Van Den Bent

, Filip de Vos

, Marica Eoli, Juan Manuel Sepulveda, Marion Smits, Annemiek Walenkamp, Jean-Sebastian Frenel, Enrico Franceschi, Paul M. Clement, Olivier Chinot, Nicolas Whenham, Paul Sanghera, Michael Weller

, H. J. Dubbink, Pim French

and 10 other authors

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Martin van den Bent